Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pulmonology
Volume 2017, Article ID 9541419, 6 pages
https://doi.org/10.1155/2017/9541419
Case Report

Pulmonary Neuroendocrine Cell Hyperplasia Associated with Surfactant Protein C Gene Mutation

1Department of Pulmonary Medicine, Mayo Clinic, Jacksonville, FL, USA
2Department of Transplant Medicine, Mayo Clinic, Jacksonville, FL, USA
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA
4Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University, Baltimore, MD, USA

Correspondence should be addressed to Norlalak Jiramethee; moc.em@anij_rd

Received 15 May 2017; Revised 28 July 2017; Accepted 3 October 2017; Published 9 November 2017

Academic Editor: Coline van Moorsel

Copyright © 2017 Norlalak Jiramethee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Marshall, A. Puddicombe, W. O. C. Cookson, and G. J. Laurent, “Adult familial cryptogenic fibrosing alveolitis in the United Kingdom,” Thorax, vol. 55, no. 2, pp. 143–146, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Hodgson, T. Laitinen, and P. Tukiainen, “Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: Evidence of founder effect among multiplex families in Finland,” Thorax, vol. 57, no. 4, pp. 338–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. P. Steele, M. C. Speer, J. E. Loyd et al., “Clinical and pathologic features of familial interstitial pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 9, pp. 1146–1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Q. Thomas, K. Lane, J. Phillips III et al., “Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 9, pp. 1322–1328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Talbert and D. A. Schwartz, “Pulmonary Fibrosis, Familial,” in GeneReviews(R), R. A. Pagon et al., Ed., Seattle, Washington DC, USA, 1993. View at Google Scholar
  6. L. M. Nogee, “Alterations in SP-B and SP-C expression in neonatal lung disease,” Annual Review of Physiology, vol. 66, pp. 601–623, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Hamvas, L. M. Nogee, F. V. White et al., “Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene,” American Journal of Respiratory Cell and Molecular Biology, vol. 30, no. 6, pp. 771–776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. A. Taam, F. Jaubert, S. Emond et al., “Familial interstitial disease with I73T mutation: a mid- and long-term study,” Pediatric Pulmonology, vol. 44, no. 2, pp. 167–175, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. Nogee, A. E. Dunbar, S. E. Wert, F. Askin, A. Hamvas, and J. A. Whitsett, “A mutation in the surfactant protein C gene associated with familial interstitial lung disease,” The New England Journal of Medicine, vol. 344, no. 8, pp. 573–579, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. H. S. Cameron, M. Somaschini, P. Carrera et al., “A common mutation in the surfactant protein C gene associated with lung disease,” Journal of Pediatrics, vol. 146, no. 3, pp. 370–375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Mechri, R. Epaud, S. Emond et al., “Surfactant protein C gene (SFTPC) mutation-associated lung disease: high-resolution computed tomography (HRCT) findings and its relation to histological analysis,” Pediatric Pulmonology, vol. 45, no. 10, pp. 1021–1029, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. O. Solarin, W.-J. Wang, and M. F. Beers, “Synthesis and post-translational processing of surfactant protein C,” Pediatric Pathology &​ Molecular Medicine, vol. 20, no. 6, pp. 471–500, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Chibbar, F. Shih, M. Baga et al., “Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis,” Modern Pathology: An Official Journal of The United States And Canadian Academy of Pathology, vol. 17, no. 8, pp. 973–980, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Salerno, D. Peca, L. Menchini et al., “Surfactant Protein C-associated interstitial lung disease; three different phenotypes of the same SFTPC mutation,” Italian Journal of Pediatrics, vol. 42, no. 1, p. 23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. G. H. Deutsch et al., “Diffuse lung disease in young children: application of a novel classification scheme,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 11, pp. 1120–1128, 2007. View at Google Scholar
  16. M. Tredano, M. Griese, F. Brasch et al., “Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease,” American Journal of Medical Genetics. Part A, vol. 126A, no. 1, pp. 18–26, 2004. View at Google Scholar · View at Scopus
  17. S. E. Wert, J. A. Whitsett, and L. M. Nogee, “Genetic disorders of surfactant dysfunction,” Pediatric and Developmental Pathology, vol. 12, no. 4, pp. 253–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Cutz, “Hyperplasia of pulmonary neuroendocrine cells in infancy and childhood,” Seminars in Diagnostic Pathology, vol. 32, no. 6, pp. 420–437, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Gosney, “Pulmonary neuroendocrine cell system in pediatric and adult lung disease,” Microscopy Research and Technique, vol. 37, no. 1, pp. 107–113, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. M. B. Schindler, D. J. Bohn, A. C. Bryan, E. Cutz, and M. Rabinovitch, “Increased respiratory system resistance and bronchial smooth muscle hypertrophy in children with acute postoperative pulmonary hypertension,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 4, part 1, pp. 1347–1352, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Heath, M. Yacoub, J. R. Gosney, B. Madden, A. W. Caslin, and P. Smith, “Pulmonary endocrine cells in hypertensive pulmonary vascular disease,” Histopathology, vol. 16, no. 1, pp. 21–28, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. D. E. Johnson, J. D. Wobken, and B. G. Landrum, “Changes in bombesin, calcitonin, and serotonin immunoreactive pulmonary neuroendocrine cells in cystic fibrosis and after prolonged mechanical ventilation,” American Review of Respiratory Disease, vol. 137, no. 1, pp. 123–131, 1988. View at Publisher · View at Google Scholar · View at Scopus
  23. L. L. Carr, J. H. Chung, R. D. Achcar et al., “The clinical course of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia,” CHEST, vol. 147, no. 2, pp. 415–422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Langston and M. K. Dishop, “Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies,” Pediatric and Developmental Pathology, vol. 12, no. 6, pp. 421–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. G. Yancheva, A. Velani, A. Rice et al., “Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD),” Histopathology, vol. 67, no. 4, pp. 501–508, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. J. R. Gosney, M. C. J. Sissons, and R. O. Allibone, “Neuroendocrine cell populations in normal human lungs: a quantitative study,” Thorax, vol. 43, no. 11, pp. 878–882, 1988. View at Publisher · View at Google Scholar · View at Scopus
  27. W. D. Travis, E. Brambilla, and H. K. Muller-Hermelink, “World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart,” in World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, W. D. Travis, E. Brambilla, H. K. Muller-Hermelink, and C. C. Harris, Eds., IARC Press, Lyon, France, 2004. View at Google Scholar
  28. A. M. Marchevsky, E. Wirtschafter, and A. E. Walts, “The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?” Human Pathology, vol. 46, no. 2, pp. 176–181, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. W. D. Travis et al., “The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification,” Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, vol. 10, no. 9, pp. 1243–1260, 2015. View at Google Scholar
  30. C. Kröner, S. Reu, V. Teusch et al., “Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients,” European Respiratory Journal, vol. 46, no. 1, pp. 197–206, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Cottin, P. Reix, C. Khouatra, F. Thivolet-Béjui, D. Feldmann, and J.-F. Cordier, “Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation,” Thorax, vol. 66, no. 10, pp. 918-919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. H. M. van Moorsel, M. F. M. van Oosterhout, N. P. Barlo et al., “Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 11, pp. 1419–1425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. A. Nassar, D. E. Jaroszewski, R. A. Helmers, T. V. Colby, B. M. Patel, and F. Mookadam, “Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia—a systematic overview,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 1, pp. 8–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. L. R. Young, G. H. Deutsch, R. E. Bokulic, A. S. Brody, and L. M. Nogee, “A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy,” CHEST, vol. 144, no. 4, pp. 1199–1206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. W. E. Lawson, S. W. Grant, V. Ambrosini et al., “Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF,” Thorax, vol. 59, no. 11, pp. 977–980, 2004. View at Publisher · View at Google Scholar · View at Scopus